“Analysts Say ‘Buy the Pullback’ in These 3 Stocks”
March 23, 2021
“Iovance Biotherapeutics (IOVA)…
The cutting edge med tech has attracted attention from Pantginis’ colleagues, as well. The stock has 5 recent reviews, and all are to Buy, making for a unanimous Strong Buy analyst consensus rating. IOVA has an average price target of $54.80, suggesting a 12-month upside of 72% from the share price of $31.88…
Quidel Corporation (QDEL)…
Turning now to the rest of the Street, where QDEL receives mostly Buys from Nowak’s colleagues – 3, as it happens. An additional 1 Sell can’t detract from a Moderate Buy consensus rating. Given the $239 average price target, the analysts expect shares to rise by 71% from current levels…
Sunrun, Inc. (RUN)…
The Truist view on Sunrun is no outlier; there are 14 reviews of this stock, and they include 11 Buys against just 3 Holds, giving the stock a Strong Buy consensus rating. Shares are priced at $57.28 and their $82.10 average price target suggests an upside of 44%…”
https://finance.yahoo.com/news/analysts-buy-pullback-3-stocks-151133486.html